43.00% -0.045

Vincerx Pharma Inc (VINC)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Vincerx Pharma Inc Stock (VINC) Company Profile

Vincerx Pharma Inc

Healthcare (1170)

Biotechnology (671)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

VINC's Discussions on Twitter

Vergleichen Sie VINC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VINC Vincerx Pharma Inc	0.055	0	0	-48.85M	-46.25M	-2.31
ONC Beigene Ltd Adr	228.38	25.07B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	438.65	109.14B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.27	36.39M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	594.32	56.98B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	71.31	5.39B	0	-153.72M	-103.81M	-2.00

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-01-14	Eingeleitet	H.C. Wainwright	Buy
2021-12-23	Eingeleitet	Cantor Fitzgerald	Overweight
2021-11-01	Eingeleitet	SVB Leerink	Outperform
2021-09-13	Eingeleitet	Laidlaw	Buy
2021-08-25	Eingeleitet	B. Riley Securities	Buy

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Finanzdaten der Vincerx Pharma Inc-Aktie (VINC)

Vincerx Pharma Inc (VINC)

Vincerx Pharma Inc Stock (VINC) Company Profile

Vergleichen Sie VINC mit anderen Aktien

Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades

Vincerx Pharma Inc Aktie (VINC) Neueste Nachrichten

Layoff Tracker: IGM Axes 80% of Workforce - BioSpace

Stock Market Recap: Vincerx Pharma Inc (VINC) Concludes at 0.26, a 1.11 Surge/Decline - DWinneX

Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com

Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX

Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com

Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister

Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga

The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com

VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa

VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India

Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa

Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView

Vincerx Pharma announces plan to delist from Nasdaq - TipRanks

Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire

Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World

Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Increases By 99.4% - The AM Reporter

vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia

vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India

Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa

VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga

Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada

Crude Oil Down 4%; Neogen Shares Plunge After Q3 ResultsBloom Energy (NYSE:BE), Neogen (NASDAQ:NEOG) - Benzinga

Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals

Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks

Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times

Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com

Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener

Failed Merger Forces Vincerx Pharma to Begin Company Wind-Down: What's Next for Investors? - Stock Titan

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com

VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa

Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World

Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView

Such Is The Power Of Vincerx Pharma Inc (NASDAQ: VINC) - Stocks Register

Finanzdaten der Vincerx Pharma Inc-Aktie (VINC)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie VINC